Durability analysis of the highly effective BNT162b2 vaccine against COVID-19

Arjun Puranik, Patrick J. Lenehan, John C. O’Horo, Michiel J.M. Niesen, Abinash Virk, Melanie D. Swift, Walter Kremers, A.J. Venkatakrishnan, Joel E. Gordon, Holly L. Geyer, Leigh Lewis Speicher, Venky Soundararajan, Andrew D. Badley
doi: https://doi.org/10.1101/2021.09.04.21263115

Data Availability

After publication, the data will be made available upon reasonable requests to the corresponding authors. A proposal with a detailed description of study objectives and the statistical analysis plan will be needed for evaluation of the reasonability of requests. Deidentified data will be provided after approval from the corresponding authors and the Mayo Clinic.

Back to top
Posted September 07, 2021.
Download PDF
Data/Code
Email
Durability analysis of the highly effective BNT162b2 vaccine against COVID-19
Arjun Puranik, Patrick J. Lenehan, John C. O’Horo, Michiel J.M. Niesen, Abinash Virk, Melanie D. Swift, Walter Kremers, A.J. Venkatakrishnan, Joel E. Gordon, Holly L. Geyer, Leigh Lewis Speicher, Venky Soundararajan, Andrew D. Badley
medRxiv 2021.09.04.21263115; doi: https://doi.org/10.1101/2021.09.04.21263115
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area